PLSE - Pulse Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$30.00
DETAILS
HIGH:
$30.00
LOW:
$30.00
MEDIAN:
$30.00
CONSENSUS:
$30.00
UPSIDE:
15.60%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue | 0.3 | 0 | 0 | 0.7 | 1.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 1.6 | 0 | 1.2 | 11.9 | 2.0 | 1.1 | 0.7 | 0.7 | 0.7 | 0.7 | 0 | 0 |
| Gross Profit | (1.3) | 0 | (1.2) | (11.2) | (0.6) | (1.1) | (0.7) | (0.7) | (0.7) | (0.7) | 0 | 0 |
| Operating Expenses | ||||||||||||
| R&D Expenses | 44.7 | 32.3 | 27.8 | 20.8 | 28.6 | 26.4 | 25.0 | 17.3 | 9.6 | 6.0 | 2.6 | 0.0 |
| SG&A Expenses | 32.0 | 23.9 | 15.8 | 26.0 | 33.8 | 22.9 | 22.3 | 20.0 | 15.5 | 2.9 | 1.2 | 0.1 |
| Other Expenses | (1.1) | 0 | (1.2) | 0 | 0 | (0.4) | 0.7 | (0.0) | 0.7 | 0.7 | 0.7 | 0 |
| Operating Expenses | 75.7 | 56.3 | 42.4 | 46.8 | 62.5 | 48.9 | 48.0 | 38.0 | 25.8 | 9.6 | 4.5 | 0.5 |
| Operating Income | ||||||||||||
| Operating Income | (76.9) | (56.3) | (43.6) | (58.1) | (63.0) | (50.0) | (48.0) | (38.0) | (25.8) | (9.6) | (4.5) | (0.3) |
| Interest Expense | 0 | 0 | 1.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 4.2 | 2.7 | 2.5 | 0 | 0 | 0.1 | 1.0 | 0.4 | 0.2 | 0.1 | 0 | 0 |
| Profitability | ||||||||||||
| EBITDA | (71.7) | (55.1) | (42.4) | (56.7) | (61.9) | (48.9) | (46.8) | (36.7) | (24.6) | (8.8) | (3.8) | (0.1) |
| EBIT | (72.8) | (56.3) | (43.6) | (58.1) | (63.0) | (49.9) | (48.0) | (37.5) | (25.6) | (9.6) | (4.5) | (0.3) |
| Income Before Tax | (72.8) | (53.6) | (42.2) | (58.5) | (63.7) | (49.9) | (47.0) | (37.5) | (25.6) | (9.5) | (4.5) | (0.5) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) | 0 | (0.1) | (1.7) | (0.0) |
| Net Income | (72.8) | (53.6) | (42.2) | (58.5) | (63.7) | (49.7) | (46.0) | (37.5) | (25.6) | (9.5) | (2.8) | (0.5) |
| Per Share Data | ||||||||||||
| EPS (Basic) | -1.08 | -0.92 | -0.88 | -1.72 | -2.28 | -2.14 | -2.22 | -2.20 | -1.73 | -0.86 | -0.37 | -0.19 |
| EPS (Diluted) | -1.08 | -0.92 | -0.88 | -1.72 | -2.28 | -2.14 | -2.22 | -2.20 | -1.73 | -0.86 | -0.37 | -0.19 |
| Shares Outstanding | 67.4 | 58.4 | 48.0 | 33.9 | 28.0 | 23.2 | 20.7 | 17.1 | 14.8 | 11.0 | 7.6 | 2.5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 80.7 | 118.0 | 44.4 | 61.1 | 28.6 | 12.5 | 6.9 | 51.1 | 3.4 | 2.1 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 8.0 | 18.5 | 8.5 | 34.7 | 14.3 |
| Net Receivables | 0.3 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0.1 | 0 | 0 | 0 | 5.8 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 2.3 | 1.4 | 1.0 | 1.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 83.4 | 119.4 | 45.3 | 62.1 | 36.6 | 22.3 | 26.4 | 60.4 | 38.5 | 16.7 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 7.1 | 8.3 | 8.8 | 10.0 | 11.2 | 11.9 | 7.7 | 2.2 | 2.6 | 0.3 |
| Goodwill | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 |
| Intangible Assets | 0.6 | 1.2 | 1.9 | 2.6 | 3.2 | 3.9 | 4.5 | 5.2 | 5.9 | 6.5 |
| Long-Term Investments | 0 | 0 | 1.9 | (2.7) | (3.3) | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.7 | 0.7 | (1.5) | 0.4 | 0.4 | 0.4 | 0.5 | 0.1 | 0.1 | 0 |
| Total Non-Current Assets | 12.7 | 13.0 | 13.8 | 15.7 | 17.6 | 19.0 | 15.5 | 10.3 | 11.3 | 9.7 |
| Total Assets | 96.1 | 132.5 | 59.2 | 77.9 | 54.2 | 41.3 | 41.9 | 70.6 | 49.8 | 26.3 |
| Current Liabilities | ||||||||||
| Account Payables | 2.8 | 1.7 | 1.8 | 1.6 | 2.9 | 1.7 | 2.0 | 1.3 | 0.8 | 0.3 |
| Short-Term Debt | 1.6 | 0 | 0 | 0.9 | 0.4 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0.0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.6 | 1.2 | 3.2 | 0.1 | 1.5 | 3.3 | 0.2 | 0.4 | 0.4 | 0 |
| Total Current Liabilities | 7.9 | 10.1 | 6.7 | 6.0 | 8.5 | 7.6 | 4.5 | 3.1 | 2.2 | 1.0 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 65 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 1.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.2 | 1.6 | 0 |
| Total Non-Current Liabilities | 7.5 | 7.5 | 8.1 | 74.1 | 10.0 | 10.8 | 6.7 | 1.2 | 1.6 | 0.3 |
| Total Liabilities | 15.5 | 17.6 | 14.8 | 80.1 | 18.6 | 18.4 | 11.2 | 4.3 | 3.8 | 1.0 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 142.1 | 84.2 | 0.0 |
| Retained Earnings | (463.3) | (390.5) | (336.9) | (294.7) | (236.2) | (172.5) | (122.7) | (75.7) | (38.2) | (12.6) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | (0.0) | 0.0 | (0.0) | (0.1) | (0.0) |
| Total Stockholders' Equity | 80.7 | 114.9 | 44.4 | (2.2) | 35.7 | 22.9 | 30.7 | 66.3 | 46.0 | 25.3 |
| Total Liabilities & Equity | 96.1 | 132.5 | 59.2 | 77.9 | 54.2 | 41.3 | 41.9 | 70.6 | 49.8 | 26.3 |
| Debt Metrics | ||||||||||
| Total Debt | 7.5 | 8.9 | 9.1 | 76.0 | 11.2 | 11.4 | 6.7 | 0 | 0 | 0 |
| Net Debt | (73.2) | (109.1) | (35.2) | 14.8 | (17.4) | (1.1) | (0.2) | (51.1) | (3.4) | (2.1) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (72.8) | (53.6) | (42.2) | (58.5) | (63.7) | (49.9) | (47.0) | (37.5) | (25.6) | (9.5) |
| Depreciation & Amortization | 1.1 | 1.2 | 1.2 | 1.4 | 1.1 | 1.1 | 1.2 | 1.3 | 1.0 | 0.8 |
| Stock-Based Compensation | 21.5 | 13.6 | 7.2 | 5.2 | 14.6 | 10.1 | 11.3 | 12.3 | 10.9 | 0.9 |
| Change in Working Capital | (5.0) | 2.5 | 0.8 | (3.7) | (6.2) | 3.2 | 0.9 | 0.1 | 0.4 | (0.2) |
| Other Non-Cash Items | 1.2 | 0.0 | 0.0 | 8.7 | 0.0 | 0.1 | (0.5) | (0.1) | 2.1 | 0.9 |
| Operating Cash Flow | (54.1) | (36.3) | (33.0) | (47.0) | (54.1) | (35.4) | (34.2) | (23.9) | (11.1) | (8.1) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.3) | (0.1) | (0.1) | (0.4) | (0.4) | (0.4) | (0.6) | (0.3) | (2.6) | (0.1) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | (10.5) | 0 | 0 | 0 | 0.1 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | (29.0) | (78.0) | (40.3) | (43.6) | (19.1) |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 8 | 39.5 | 68.5 | 66.7 | 23.1 | 4.8 |
| Other Investing Activities | (0.0) | 0 | 0 | 0 | 0 | 10.5 | 0 | 26.4 | (20.4) | (0.1) |
| Investing Cash Flow | (0.3) | (0.1) | (0.1) | (0.4) | 7.6 | 10.0 | (10.1) | 26.1 | (23.0) | (14.4) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 65 | 0.4 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 50.5 | (0.0) | 0.1 | 62.5 | 1.5 | (0.6) | 0.7 | 0.5 | 0 |
| Financing Cash Flow | 17.2 | 110.1 | 16.4 | 79.9 | 62.7 | 30.9 | 0.1 | 45.5 | 35.4 | 20.9 |
| Cash Position | ||||||||||
| Net Change in Cash | (37.3) | 73.7 | (16.8) | 32.5 | 16.2 | 5.6 | (44.2) | 47.7 | 1.3 | (1.5) |
| Cash at Beginning | 118.0 | 44.4 | 61.1 | 28.6 | 12.5 | 6.9 | 51.1 | 3.4 | 2.1 | 3.6 |
| Cash at End | 80.7 | 118.0 | 44.4 | 61.1 | 28.6 | 12.5 | 6.9 | 51.1 | 3.4 | 2.1 |
| Free Cash Flow | (54.4) | (36.5) | (33.2) | (47.4) | (54.5) | (35.8) | (34.8) | (24.2) | (13.6) | (8.1) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | 0.3 | 0 | 0 | 0.7 | 1.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (1.3) | 0 | (1.2) | (11.2) | (0.6) | (1.1) | (0.7) | (0.7) | (0.7) | (0.7) | 0 | 0 |
| Operating Income | (76.9) | (56.3) | (43.6) | (58.1) | (63.0) | (50.0) | (48.0) | (38.0) | (25.8) | (9.6) | (4.5) | (0.3) |
| Net Income | (72.8) | (53.6) | (42.2) | (58.5) | (63.7) | (49.7) | (46.0) | (37.5) | (25.6) | (9.5) | (2.8) | (0.5) |
| EPS (Diluted) | -1.08 | -0.92 | -0.88 | -1.72 | -2.28 | -2.14 | -2.22 | -2.20 | -1.73 | -0.86 | -0.37 | -0.19 |
| Balance Sheet | ||||||||||||
| Cash & Equivalents | 80.7 | 118.0 | 44.4 | 61.1 | 28.6 | 12.5 | 6.9 | 51.1 | 3.4 | 2.1 | ||
| Total Assets | 96.1 | 132.5 | 59.2 | 77.9 | 54.2 | 41.3 | 41.9 | 70.6 | 49.8 | 26.3 | ||
| Total Debt | 7.5 | 8.9 | 9.1 | 76.0 | 11.2 | 11.4 | 6.7 | 0 | 0 | 0 | ||
| Stockholders' Equity | 80.7 | 114.9 | 44.4 | (2.2) | 35.7 | 22.9 | 30.7 | 66.3 | 46.0 | 25.3 | ||
| Cash Flow | ||||||||||||
| Operating Cash Flow | (54.1) | (36.3) | (33.0) | (47.0) | (54.1) | (35.4) | (34.2) | (23.9) | (11.1) | (8.1) | ||
| Capital Expenditure | (0.3) | (0.1) | (0.1) | (0.4) | (0.4) | (0.4) | (0.6) | (0.3) | (2.6) | (0.1) | ||
| Free Cash Flow | (54.4) | (36.5) | (33.2) | (47.4) | (54.5) | (35.8) | (34.8) | (24.2) | (13.6) | (8.1) | ||